Home Overview Press Room Blog Publications For Students about us
Search

About Media Coverage & Human Biotechnology


Until a few years ago, human biotechnologies were rarely discussed in the popular media. Now magazine covers, television shows, newspaper headlines and front-page articles showcase their development and the controversies surrounding them.

This increased coverage is welcome; sunlight can be a good disinfectant. Nevertheless, mainstream media coverage has been inadequate or misleading in several regards.

Too often it prematurely celebrates new techniques as "breakthroughs" or "medical miracles," even when they are preliminary and unconfirmed. This is particularly dangerous in a growing culture of "science by press release," where fantastic findings are often later debunked (with less fanfare) by peer review. Also, the press rarely scrutinizes scientists' and bioethicists' statements, actions, or potential conflicts of interest with the same rigor they bring to reports about other public figures.

Lastly, too few media accounts make clear the full import of what's at stake. Excitement about possible new medical therapies tends to drown out consideration of undesirable prospects including genetic discrimination, increased health inequalities, and the misuse of human biotechnologies.



LA Times columnist's concerns over CIRM echo our ownby Jesse ReynoldsBiopolitical TimesFebruary 3rd, 2010One of the most prominent political commentators in the state has again taken on California's controversial stem cell research program.
Technology Updates: Inheritable Genetic Modificationby Pete ShanksBiopolitical TimesJanuary 14th, 2010Two new technologies may make inheritable genetic modification significantly more feasible.
Nudging the Discourse?by Pete ShanksBiopolitical TimesJanuary 8th, 2010The Popular Mechanics article misleadingly titled "How to Create a Designer Baby" includes a call for regulation of assisted reproduction.
Reparations for Eugenics Victims Stall in North Carolinaby Jesse ReynoldsBiopolitical TimesJanuary 5th, 2010The Winston-Salem Journal reports that there's been negligible progress in issuing the allocated reparations.
Calls for Regulating Surrogacy in the New York Timesby Jesse ReynoldsBiopolitical TimesJanuary 5th, 2010The paper of record ran four opinions online, each calling for greater oversight of commercial surrogacy.
Technopolitics for the 21st Century: Civil Society Perspectivesby Jesse ReynoldsBiopolitical TimesDecember 22nd, 2009Last week, the blog 2020 Science published ten invited "alternative perspectives on technology innovation" by public interest advocates.
Surgeon General’s Warning: Gupta Is At It Againby Osagie ObasogieBiopolitical TimesDecember 14th, 2009Sanjay Gupta is taking his uncritical approach to biology and social outcomes to the realm of radical life extension.
Enhancement: From Steroids to Skin Toneby Osagie ObasogieBiopolitical TimesDecember 5th, 2009As during the 1998 baseball season, when Mark McGwire is in the news, Sammy Sosa isn’t far behind. And neither are troubling questions about enhancement. Sosa shocked many a few weeks ago by appearing at the Latin Grammys with dramatically lighter skin.
Hot Air and Cat Hypeby Pete ShanksBiopolitical TimesDecember 3rd, 2009Allerca Lifestyle Pets is getting out of the hypoallergenic cat business - if it was ever really in it.
Cautious Optimism about Limited Gene Therapyby Pete ShanksBiopolitical TimesNovember 23rd, 2009Modestly encouraging signs of progress in gene therapy are welcome but should not be exaggerated.
Displaying 1-10 of 153  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.625.0819 • (F) 1.510.625.0874